Department of Biotechnology, Norwegian University of Science and Technology, Trondheim, Norway.
Biomaterials. 2010 Feb;31(5):975-87. doi: 10.1016/j.biomaterials.2009.09.102. Epub 2009 Oct 25.
Chitosan is an attractive gene delivery vehicle, but the criteria and strategies for the design of efficient chitosan gene delivery systems remain unclear. The purpose of this work was to investigate how the strength of the charge-based interaction between chitosan and DNA determines the gene expression levels and to design chitosan vectors with an optimized balance between polyplex stability and polyplex unpacking. Using 21 formulations based on low molecular weight chitosans with constant charge density and a number-average degree of polymerization (DPn) in the range of 21-88 (M(w) 4.7-33kDa), we studied the relationship between the chain length and the formulation properties, cellular uptake of polyplexes and gene transfer efficacy. We were able to identify a narrow interval of DPn31-42 that mediated the maximum level of transgene expression. An increase in chain length and/or the amino-phosphate (A/P) ratio reduced and delayed transgene expression. Compared to DPn31, transfection with the same amount of DPn72 or DPn88 resulted in 10-fold-lower expression levels. The gene transfer pattern correlated with the ability of heparin to release DNA from the polyplexes. As a tool to facilitate the unpacking of the polyplexes, we substituted the chitosans with uncharged oligosaccharides that reduced the interaction with DNA. The substitution of chitosans that originally yielded too stable polyplexes, such as DPn72 and DPn88 resulted in a 5-10-fold enhancement of the expression levels. However, the substitution of chitosans shorter than DP28 completely abolished transfection. Tailoring of the chain length and the substitution of chitosan were shown to be feasible tools to modulate the electrostatic interactions between the chitosan and DNA and to design chitosans with an optimized balance between polyplex stability and polyplex unpacking.
壳聚糖是一种有吸引力的基因传递载体,但高效壳聚糖基因传递系统的设计标准和策略仍不清楚。本工作旨在研究壳聚糖与 DNA 之间基于电荷的相互作用强度如何决定基因表达水平,并设计具有优化的多聚物稳定性和解包平衡的壳聚糖载体。使用基于低分子量壳聚糖的 21 种制剂,其恒定电荷密度和数均聚合度(DPn)范围为 21-88(M(w)4.7-33kDa),我们研究了链长与制剂特性、多聚物摄取和基因转移效率之间的关系。我们能够确定一个狭窄的 DPn31-42 区间,该区间介导了最大水平的转基因表达。链长的增加和/或氨基-磷酸(A/P)比的降低和延迟了转基因表达。与 DPn31 相比,用相同量的 DPn72 或 DPn88 转染导致表达水平降低 10 倍。基因转移模式与肝素从多聚物中释放 DNA 的能力相关。作为促进多聚物解包的工具,我们用非带电寡糖替代壳聚糖,从而降低与 DNA 的相互作用。取代原本生成太稳定的多聚物的壳聚糖,如 DPn72 和 DPn88,导致表达水平提高 5-10 倍。然而,取代短于 DP28 的壳聚糖完全消除了转染。链长的调整和壳聚糖的取代被证明是调节壳聚糖与 DNA 之间静电相互作用的可行工具,并设计了具有优化的多聚物稳定性和解包平衡的壳聚糖。